Annual SGA
$468.95 M
-$19.75 M-4.04%
December 31, 2023
Summary
- As of February 26, 2025, NVAX annual SGA is $468.95 million, with the most recent change of -$19.75 million (-4.04%) on December 31, 2023.
- During the last 3 years, NVAX annual SGA has risen by +$323.66 million (+222.77%).
- NVAX annual SGA is now -4.04% below its all-time high of $488.69 million, reached on December 31, 2022.
Performance
NVAX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$70.75 M
-$30.55 M-30.16%
September 30, 2024
Summary
- As of February 26, 2025, NVAX quarterly SGA is $70.75 million, with the most recent change of -$30.55 million (-30.16%) on September 30, 2024.
- Over the past year, NVAX quarterly SGA has dropped by -$36.71 million (-34.16%).
- NVAX quarterly SGA is now -56.24% below its all-time high of $161.66 million, reached on December 31, 2022.
Performance
NVAX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$19.52 B
-$284.86 M-1.48%
September 30, 2024
Summary
- As of February 26, 2025, NVAX TTM SGA is -$19.52 billion, with the most recent change of -$284.86 million (-1.48%) on September 30, 2024.
- Over the past year, NVAX TTM SGA has dropped by -$20.00 billion (-4206.89%).
- NVAX TTM SGA is now -86668.85% below its all-time high of -$22.50 million.
Performance
NVAX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVAX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.0% | -34.2% | -4206.9% |
| 3 y3 years | +222.8% | -16.0% | -6643.5% |
| 5 y5 years | +1262.9% | +654.3% | -10000.0% |
NVAX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | +57.2% | -56.2% | at low | -78.5% | at low |
| 5 y | 5-year | -4.0% | +1262.5% | -56.2% | +764.8% | -251.4% | at low |
| alltime | all time | -4.0% | >+9999.0% | -56.2% | >+9999.0% | <-9999.0% | at low |
Novavax Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $70.75 M(-30.2%) | $414.08 M(-8.1%) |
| Jun 2024 | - | $101.30 M(+16.7%) | $450.79 M(+1.7%) |
| Mar 2024 | - | $86.80 M(-44.1%) | $443.21 M(-5.5%) |
| Dec 2023 | $468.95 M(-4.0%) | $155.24 M(+44.5%) | $468.95 M(-1.4%) |
| Sep 2023 | - | $107.46 M(+14.7%) | $475.37 M(-3.1%) |
| Jun 2023 | - | $93.72 M(-16.7%) | $490.79 M(-2.9%) |
| Mar 2023 | - | $112.53 M(-30.4%) | $505.23 M(+3.4%) |
| Dec 2022 | $488.69 M(+63.8%) | $161.66 M(+31.6%) | $488.69 M(+18.8%) |
| Sep 2022 | - | $122.88 M(+13.6%) | $411.24 M(+12.3%) |
| Jun 2022 | - | $108.16 M(+12.7%) | $366.16 M(+10.6%) |
| Mar 2022 | - | $95.99 M(+14.0%) | $331.16 M(+11.0%) |
| Dec 2021 | $298.36 M(+105.4%) | $84.21 M(+8.3%) | $298.36 M(+8.3%) |
| Sep 2021 | - | $77.79 M(+6.3%) | $275.46 M(+8.2%) |
| Jun 2021 | - | $73.16 M(+15.8%) | $254.54 M(+27.8%) |
| Mar 2021 | - | $63.19 M(+3.1%) | $199.10 M(+37.0%) |
| Dec 2020 | $145.29 M(+322.1%) | $61.31 M(+7.8%) | $145.29 M(+57.7%) |
| Sep 2020 | - | $56.88 M(+221.0%) | $92.16 M(+113.4%) |
| Jun 2020 | - | $17.72 M(+88.9%) | $43.18 M(+23.1%) |
| Mar 2020 | - | $9.38 M(+14.6%) | $35.06 M(+1.9%) |
| Dec 2019 | $34.42 M(+0.0%) | $8.18 M(+3.6%) | $34.42 M(-2.9%) |
| Sep 2019 | - | $7.90 M(-17.8%) | $35.46 M(-1.1%) |
| Jun 2019 | - | $9.61 M(+10.0%) | $35.87 M(+4.0%) |
| Mar 2019 | - | $8.73 M(-5.3%) | $34.49 M(+0.2%) |
| Dec 2018 | $34.41 M(-0.1%) | $9.22 M(+11.0%) | $34.41 M(+2.0%) |
| Sep 2018 | - | $8.31 M(+1.0%) | $33.73 M(+0.6%) |
| Jun 2018 | - | $8.22 M(-4.9%) | $33.53 M(-2.1%) |
| Mar 2018 | - | $8.65 M(+1.3%) | $34.25 M(-0.6%) |
| Dec 2017 | $34.45 M(-26.0%) | $8.54 M(+5.2%) | $34.45 M(+0.6%) |
| Sep 2017 | - | $8.12 M(-9.2%) | $34.25 M(-13.7%) |
| Jun 2017 | - | $8.94 M(+1.0%) | $39.69 M(-11.5%) |
| Mar 2017 | - | $8.85 M(+6.1%) | $44.85 M(-3.6%) |
| Dec 2016 | $46.53 M(+50.9%) | $8.34 M(-38.4%) | $46.53 M(-1.1%) |
| Sep 2016 | - | $13.56 M(-3.9%) | $47.03 M(+10.6%) |
| Jun 2016 | - | $14.10 M(+33.9%) | $42.54 M(+19.7%) |
| Mar 2016 | - | $10.53 M(+18.9%) | $35.53 M(+15.2%) |
| Dec 2015 | $30.84 M(+54.8%) | $8.85 M(-2.3%) | $30.84 M(+14.0%) |
| Sep 2015 | - | $9.06 M(+27.8%) | $27.05 M(+18.9%) |
| Jun 2015 | - | $7.09 M(+21.3%) | $22.75 M(+6.0%) |
| Mar 2015 | - | $5.84 M(+15.5%) | $21.46 M(+7.7%) |
| Dec 2014 | $19.93 M(+34.5%) | $5.06 M(+6.3%) | $19.93 M(+5.2%) |
| Sep 2014 | - | $4.76 M(-18.1%) | $18.95 M(+5.0%) |
| Jun 2014 | - | $5.81 M(+34.8%) | $18.05 M(+11.0%) |
| Mar 2014 | - | $4.31 M(+5.6%) | $16.26 M(+9.7%) |
| Dec 2013 | $14.82 M(+46.1%) | $4.08 M(+5.8%) | $14.82 M(+12.2%) |
| Sep 2013 | - | $3.86 M(-3.9%) | $13.21 M(+15.0%) |
| Jun 2013 | - | $4.01 M(+39.8%) | $11.49 M(+15.5%) |
| Mar 2013 | - | $2.87 M(+16.1%) | $9.95 M(-1.1%) |
| Dec 2012 | $10.14 M(-7.0%) | $2.47 M(+15.8%) | $10.06 M(+5.2%) |
| Sep 2012 | - | $2.13 M(-13.6%) | $9.56 M(-5.9%) |
| Jun 2012 | - | $2.47 M(-17.3%) | $10.16 M(-7.9%) |
| Mar 2012 | - | $2.98 M(+51.2%) | $11.03 M(+1.2%) |
| Dec 2011 | $10.90 M(+0.9%) | $1.97 M(-27.9%) | $10.90 M(-2.7%) |
| Sep 2011 | - | $2.74 M(-18.0%) | $11.20 M(-0.9%) |
| Jun 2011 | - | $3.34 M(+17.1%) | $11.31 M(+1.7%) |
| Mar 2011 | - | $2.85 M(+25.2%) | $11.12 M(+2.9%) |
| Dec 2010 | $10.80 M | $2.28 M(-19.9%) | $10.80 M(-8.4%) |
| Sep 2010 | - | $2.84 M(-9.7%) | $11.79 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | $3.15 M(+24.2%) | $12.16 M(+5.1%) |
| Mar 2010 | - | $2.54 M(-22.4%) | $11.57 M(-3.0%) |
| Dec 2009 | $11.93 M(+7.6%) | $3.27 M(+1.9%) | $11.93 M(-1.2%) |
| Sep 2009 | - | $3.21 M(+25.2%) | $12.08 M(+19.2%) |
| Jun 2009 | - | $2.56 M(-11.4%) | $10.13 M(-5.6%) |
| Mar 2009 | - | $2.89 M(-15.3%) | $10.74 M(-3.2%) |
| Dec 2008 | $11.09 M(-20.6%) | $3.42 M(+170.0%) | $11.09 M(+19.5%) |
| Sep 2008 | - | $1.26 M(-60.0%) | $9.28 M(-21.7%) |
| Jun 2008 | - | $3.17 M(-2.4%) | $11.85 M(-5.3%) |
| Mar 2008 | - | $3.24 M(+102.5%) | $12.52 M(-9.8%) |
| Dec 2007 | $13.96 M(+23.7%) | $1.60 M(-58.3%) | $13.88 M(-3.4%) |
| Sep 2007 | - | $3.84 M(+0.2%) | $14.36 M(+7.7%) |
| Jun 2007 | - | $3.83 M(-16.6%) | $13.33 M(+4.1%) |
| Mar 2007 | - | $4.60 M(+120.4%) | $12.81 M(+16.8%) |
| Dec 2006 | $11.29 M(-25.4%) | $2.09 M(-25.9%) | $10.97 M(-0.1%) |
| Sep 2006 | - | $2.81 M(-15.1%) | $10.98 M(+0.8%) |
| Jun 2006 | - | $3.31 M(+20.2%) | $10.90 M(-7.0%) |
| Mar 2006 | - | $2.76 M(+31.8%) | $11.72 M(-22.6%) |
| Dec 2005 | $15.14 M(-54.2%) | $2.09 M(-23.4%) | $15.14 M(-31.5%) |
| Sep 2005 | - | $2.73 M(-34.0%) | $22.10 M(-28.5%) |
| Jun 2005 | - | $4.14 M(-33.1%) | $30.92 M(-10.1%) |
| Mar 2005 | - | $6.18 M(-31.7%) | $34.40 M(+4.2%) |
| Dec 2004 | $33.03 M(+110.0%) | $9.05 M(-21.7%) | $33.03 M(+17.7%) |
| Sep 2004 | - | $11.55 M(+51.7%) | $28.07 M(+37.4%) |
| Jun 2004 | - | $7.62 M(+58.4%) | $20.43 M(+23.5%) |
| Mar 2004 | - | $4.81 M(+17.5%) | $16.54 M(+5.2%) |
| Dec 2003 | $15.72 M(-26.9%) | $4.09 M(+4.5%) | $15.73 M(-0.7%) |
| Sep 2003 | - | $3.91 M(+5.0%) | $15.84 M(-2.6%) |
| Jun 2003 | - | $3.73 M(-6.7%) | $16.27 M(-11.1%) |
| Mar 2003 | - | $4.00 M(-5.0%) | $18.31 M(-14.8%) |
| Dec 2002 | $21.50 M(+16.3%) | $4.21 M(-3.1%) | $21.50 M(-5.5%) |
| Sep 2002 | - | $4.34 M(-24.7%) | $22.75 M(-2.1%) |
| Jun 2002 | - | $5.77 M(-19.8%) | $23.24 M(+4.7%) |
| Mar 2002 | - | $7.19 M(+31.9%) | $22.20 M(+20.0%) |
| Dec 2001 | $18.49 M(+215.7%) | $5.45 M(+12.8%) | $18.49 M(+14.6%) |
| Sep 2001 | - | $4.83 M(+2.2%) | $16.14 M(+33.1%) |
| Jun 2001 | - | $4.73 M(+35.7%) | $12.13 M(+39.4%) |
| Mar 2001 | - | $3.48 M(+12.6%) | $8.70 M(+48.5%) |
| Dec 2000 | $5.86 M(+144.1%) | $3.09 M(+276.4%) | $5.86 M(+74.1%) |
| Sep 2000 | - | $822.00 K(-36.9%) | $3.37 M(+0.7%) |
| Jun 2000 | - | $1.30 M(+103.1%) | $3.34 M(+31.6%) |
| Mar 2000 | - | $641.00 K(+6.8%) | $2.54 M(+5.9%) |
| Dec 1999 | $2.40 M(-4.0%) | $600.00 K(-25.0%) | $2.40 M(0.0%) |
| Sep 1999 | - | $800.00 K(+60.0%) | $2.40 M(+9.1%) |
| Jun 1999 | - | $500.00 K(0.0%) | $2.20 M(-8.3%) |
| Mar 1999 | - | $500.00 K(-16.7%) | $2.40 M(0.0%) |
| Dec 1998 | $2.50 M(+4.2%) | $600.00 K(0.0%) | $2.40 M(+4.3%) |
| Sep 1998 | - | $600.00 K(-14.3%) | $2.30 M(0.0%) |
| Jun 1998 | - | $700.00 K(+40.0%) | $2.30 M(+4.5%) |
| Mar 1998 | - | $500.00 K(0.0%) | $2.20 M(-4.3%) |
| Dec 1997 | $2.40 M(+26.3%) | $500.00 K(-16.7%) | $2.30 M(-4.2%) |
| Sep 1997 | - | $600.00 K(0.0%) | $2.40 M(+14.3%) |
| Jun 1997 | - | $600.00 K(0.0%) | $2.10 M(+5.0%) |
| Mar 1997 | - | $600.00 K(0.0%) | $2.00 M(+11.1%) |
| Dec 1996 | $1.90 M | $600.00 K(+100.0%) | $1.80 M(+50.0%) |
| Sep 1996 | - | $300.00 K(-40.0%) | $1.20 M(+33.3%) |
| Jun 1996 | - | $500.00 K(+25.0%) | $900.00 K(+125.0%) |
| Mar 1996 | - | $400.00 K | $400.00 K |
FAQ
- What is Novavax annual SGA?
- What is the all time high annual SGA for Novavax?
- What is Novavax annual SGA year-on-year change?
- What is Novavax quarterly SGA?
- What is the all time high quarterly SGA for Novavax?
- What is Novavax quarterly SGA year-on-year change?
- What is Novavax TTM SGA?
- What is the all time high TTM SGA for Novavax?
- What is Novavax TTM SGA year-on-year change?
What is Novavax annual SGA?
The current annual SGA of NVAX is $468.95 M
What is the all time high annual SGA for Novavax?
Novavax all-time high annual SGA is $488.69 M
What is Novavax annual SGA year-on-year change?
Over the past year, NVAX annual SGA has changed by -$19.75 M (-4.04%)
What is Novavax quarterly SGA?
The current quarterly SGA of NVAX is $70.75 M
What is the all time high quarterly SGA for Novavax?
Novavax all-time high quarterly SGA is $161.66 M
What is Novavax quarterly SGA year-on-year change?
Over the past year, NVAX quarterly SGA has changed by -$36.71 M (-34.16%)
What is Novavax TTM SGA?
The current TTM SGA of NVAX is -$19.52 B
What is the all time high TTM SGA for Novavax?
Novavax all-time high TTM SGA is -$22.50 M
What is Novavax TTM SGA year-on-year change?
Over the past year, NVAX TTM SGA has changed by -$20.00 B (-4206.89%)